Nakamura Tomoki, Chino Osamu, Yokoyama Daiki, Tanaka Yoichi, Hanashi Tomoko, Kikuchi Masahiro, Ogawa Takafumi, Tajima Takayuki, Sadahiro Sotaro, Kondoh Yasumasa, Makuuchi Hiroyasu
Department of Surgery, Tokai University School of Medicine Tokyo Hospital, 1-2-5 Yoyogi, Shibuya-ku, Tokyo 151-0053, Japan.
Tokai J Exp Clin Med. 2016 Mar 20;41(1):30-4.
The patient was a 70-year-old man. Hepatic dysfunction was found in 1988 and chronic hepatitis C was diagnosed in 1993. He received interferon-alpha therapy, but did not respond to it. Thereafter, he was treated with ursodeoxycholic acid. In September 2010, abdominal ultrasound showed a hypoechoic tumor (29 × 25 mm) in the lower pole of the spleen, and this lesion became larger one year later (74 × 66 × 71 mm). Abdominal CT revealed a hypovascular heterogeneous tumor with smooth margins on both dynamic and delayed phase scans. MRI displayed a tumor with a low signal intensity on T2WI. Abdominal angiography confirmed that the lesion was hypovascular. 67Ga scintigraphy showed abnormal accumulation confined to the spleen. Bone marrow biopsy did not reveal any abnormalities. Based on these findings, primary splenic malignant lymphoma (PSML) complicating chronic hepatitis C was diagnosed and splenectomy was performed. A tumor (78 × 60 mm) was found in the lower pole of the resected spleen and pathologic examination revealed diffuse large B cell lymphoma (DLBCL). Four courses of postoperative R-CHOP therapy were performed. At present, he continues to use ursodeoxycholic acid with no recurrence after four years. In conclusion, we report our experience of a patient who had PSML complicating chronic hepatitis C with discussion of the literature.
患者为一名70岁男性。1988年发现肝功能障碍,1993年诊断为慢性丙型肝炎。他接受了α干扰素治疗,但无反应。此后,他接受了熊去氧胆酸治疗。2010年9月,腹部超声显示脾脏下极有一个低回声肿瘤(29×25mm),一年后该病变增大(74×66×71mm)。腹部CT显示在动态和延迟期扫描中,该肿瘤为低血供、不均匀,边缘光滑。MRI显示该肿瘤在T2WI上呈低信号强度。腹部血管造影证实该病变为低血供。67Ga闪烁扫描显示异常聚集仅限于脾脏。骨髓活检未发现任何异常。基于这些发现,诊断为合并慢性丙型肝炎的原发性脾恶性淋巴瘤(PSML)并进行了脾切除术。在切除的脾脏下极发现一个肿瘤(78×60mm),病理检查显示为弥漫性大B细胞淋巴瘤(DLBCL)。术后进行了四个疗程的R-CHOP治疗。目前,他继续使用熊去氧胆酸,四年后无复发。总之,我们报告了一名合并慢性丙型肝炎的PSML患者的经验并对文献进行了讨论。